behavioral rating

Methods 46 patients with AD were assessed with the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD), mini mental state examination ( MMSE) and the clinic dementia rating ( CDR) at the day of hospitalized.

方法46例AD患者在入院当天作AD病理行为评分表（BEHAVE-AD）、简易智力状态检查（MMSE）及临床痴呆评定表（CDR）评定。

BPSD were assessed with the Behavioral Pathology in Alzheimer Disease Rating Scale ( BEHAVE AD) and the Cohen Mansfield Agitation Inventory ( CMAI).

采用Alzheimer病行为症状评定量表（BEHAVE-AD）、Cohen-Masfield激惹性问卷（CMAI）评定痴呆患者BPSD。

Objective: To assess the reliability and validity of the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD).

目的：评定阿尔茨海默病（AD）病理行为评分表（BEHAVE-AD）的信度和效度。

The therapeutic response and side effects were evaluated with the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD) and treatment emergent symptom scale ( TESS).

用AD病理行为评分表评价疗效，药物副作用量表评价不良反应。

To estimate BPSD in AD patients with behavioral pathology in Alzheimer disease rating scale.

采用AD病理行为量表评定病人的行为和精神症状。